Replies to post #3556 on Innovus Pharmaceuticals Inc. (fka INNV)

[s_Henderson]

Yes they should have. It's completely ridiculous to even talk about "launching RecalMax" when the exact same product (just with a different name) has been in the portofolio for months/years? I will ask IR about this.